Oppenheimer & Co. Inc. Has $1.61 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

Oppenheimer & Co. Inc. cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 15.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,108 shares of the company's stock after selling 5,527 shares during the period. Oppenheimer & Co. Inc.'s holdings in Doximity were worth $1,607,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the company. Oppenheimer Asset Management Inc. raised its stake in Doximity by 13.1% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 19,075 shares of the company's stock worth $1,018,000 after purchasing an additional 2,212 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in shares of Doximity by 2.4% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 26,100 shares of the company's stock valued at $1,393,000 after buying an additional 600 shares in the last quarter. Los Angeles Capital Management LLC boosted its stake in shares of Doximity by 33.7% in the fourth quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company's stock valued at $46,466,000 after buying an additional 219,448 shares during the period. Amalgamated Bank increased its stake in Doximity by 2.3% during the 4th quarter. Amalgamated Bank now owns 60,742 shares of the company's stock worth $3,243,000 after acquiring an additional 1,343 shares during the period. Finally, IFP Advisors Inc lifted its position in shares of Doximity by 344.1% during the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company's stock valued at $71,000 after acquiring an additional 1,029 shares during the period. Institutional investors own 87.19% of the company's stock.

Remove Ads

Doximity Stock Performance

Shares of DOCS stock traded down $1.87 on Friday, hitting $64.09. The company had a trading volume of 1,918,168 shares, compared to its average volume of 2,433,625. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The firm has a market cap of $11.96 billion, a P/E ratio of 64.09, a P/E/G ratio of 4.10 and a beta of 1.34. The stock's 50-day moving average is $62.68 and its two-hundred day moving average is $51.41.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DOCS. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Morgan Stanley upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. Stephens began coverage on Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 target price on the stock. JPMorgan Chase & Co. boosted their price target on Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a report on Thursday, November 21st. Finally, Raymond James restated an "outperform" rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $64.22.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 37.40% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.